Boiron SA
PAR:BOI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Boiron SA
Operating Income
Boiron SA
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Boiron SA
PAR:BOI
|
Operating Income
€26.5m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-16%
|
|
|
Sanofi SA
PAR:SAN
|
Operating Income
€10.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
4%
|
|
|
Ipsen SA
PAR:IPN
|
Operating Income
€963.1m
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
|
|
Vetoquinol SA
PAR:VETO
|
Operating Income
€79.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
|
|
Virbac SA
PAR:VIRP
|
Operating Income
€230.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
14%
|
CAGR 10-Years
21%
|
|
|
Medincell SA
PAR:MEDCL
|
Operating Income
-€9.9m
|
CAGR 3-Years
26%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Boiron SA
Glance View
Boiron SA engages in the manufacturing and selling homeopathic medicines. The company is headquartered in Rontalon, Auvergne-Rhone-Alpes. The firm develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. The company also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.
See Also
What is Boiron SA's Operating Income?
Operating Income
26.5m
EUR
Based on the financial report for Jun 30, 2025, Boiron SA's Operating Income amounts to 26.5m EUR.
What is Boiron SA's Operating Income growth rate?
Operating Income CAGR 10Y
-16%
Over the last year, the Operating Income growth was -11%. The average annual Operating Income growth rates for Boiron SA have been -30% over the past three years , -16% over the past five years , and -16% over the past ten years .